pi3k inhibitors in r/r dlbcl
Published 2 years ago • 119 plays • Length 2:44Download video MP4
Download video MP3
Similar videos
-
1:18
the current status of pi3k inhibitors in hematological malignancies and challenges to overcome
-
1:41
the role of pi3k inhibitors in cll
-
2:56
side effects of novel pi3k inhibitors
-
3:40
pi3k inhibitors for cll
-
1:21
overview of the role of non-covalent btk inhibitors in the era of covalent btk inhibitors
-
1:40
second-generation flt3 inhibitors in the treatment of flt3-itd aml
-
1:04
mp0533, a cd3-engaging darpin, in r/r aml or mds/aml: preliminary results of a phase i/iia trial
-
25:30
hemolyzer 3 pro
-
21:38
drawing the line: the rationale behind blood tube collection order
-
4:06
rt-pcr testing procedure in huo-yan laboratory
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:46
preclinical efficacy of the pkcβ inhibitor ms-553 in btki resistant cll
-
1:34
the promise of second-generation pi3k inhibitors for cll
-
3:47
pi3k inhibitors in management of r/r follicular lymphoma
-
0:46
xport-mf-034: selinexor plus ruxolitinib in jak-inhibitor naïve myelofibrosis
-
2:02
pi3k inhibition for r/r follicular lymphoma
-
1:00
the role of non-covalent btk inhibitors in the treatment of non-hodgkin lymphoma
-
0:55
insights into the real-world evidence for c3 inhibition in the treatment of pnh
-
0:52
highlights from icle 2022
-
2:09
heart transplantation in attr amyloidosis
-
3:55
ziftomenib: a menin inhibitor for r/r npm1-mutated aml